Goldman Sachs’s Pfizer PFE Stock Holding History

Goldman Sachs’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32B	Buy	47,105,556 +7,049,994	+18%	+$188M	0.17%	113
2025 Q4	$997M	Buy	40,055,562 +7,240,124	+22%	+$183M	0.14%	142
2025 Q3	$836M	Buy	32,815,438 +2,473,524	+8%	+$61.1M	0.12%	175
2025 Q2	$735M	Buy	30,341,914 +4,789,757	+19%	+$112M	0.12%	187
2025 Q1	$647M	Buy	25,552,157 +8,233,390	+48%	+$215M	0.12%	181
2024 Q4	$459M	Sell	17,318,767 -8,507,851	-33%	-$231M	0.09%	247
2024 Q3	$747M	Sell	25,826,618 -9,090,121	-26%	-$265M	0.14%	156
2024 Q2	$977M	Buy	34,916,739 +12,569,585	+56%	+$346M	0.19%	107
2024 Q1	$620M	Sell	22,347,154 -1,722,272	-7%	-$47.8M	0.13%	178
2023 Q4	$693M	Sell	24,069,426 -511,767	-2%	-$15.5M	0.15%	159
2023 Q3	$815M	Sell	24,581,193 -1,627,801	-6%	-$57.6M	0.21%	108
2023 Q2	$961M	Buy	26,208,994 +2,397,511	+10%	+$93.3M	0.25%	79
2023 Q1	$972M	Sell	23,811,483 -1,172,040	-5%	-$50.6M	0.26%	69
2022 Q4	$1.28B	Buy	24,983,523 +3,053,993	+14%	+$146M	0.37%	42
2022 Q3	$960M	Buy	21,929,530 +63,669	+0.3%	+$3.09M	0.28%	64
2022 Q2	$1.15B	Buy	21,865,861 +2,033,150	+10%	+$104M	0.33%	50
2022 Q1	$1.03B	Buy	19,832,711 +2,090,429	+12%	+$108M	0.26%	65
2021 Q4	$1.05B	Sell	17,742,282 -890,845	-5%	-$44.1M	0.25%	67
2021 Q3	$801M	Buy	18,633,127 +3,225,374	+21%	+$143M	0.21%	98
2021 Q2	$603M	Sell	15,407,753 -2,100,986	-12%	-$81.7M	0.16%	132
2021 Q1	$634M	Buy	17,508,739 +1,122,647	+7%	+$39.9M	0.19%	103
2020 Q4	$603M	Buy	16,386,092 +260,698	+2%	+$9.56M	0.2%	113
2020 Q3	$561M	Sell	16,125,394 -16,749,644	-51%	-$587M	0.2%	107
2020 Q2	$1.02B	Sell	32,875,038 -2,040,189	-6%	-$69.3M	0.35%	46
2020 Q1	$1.08B	Sell	34,915,227 -12,065,498	-26%	-$411M	0.43%	37
2019 Q4	$1.75B	Buy	46,980,725 +3,671,768	+8%	+$131M	0.5%	24
2019 Q3	$1.48B	Buy	43,308,957 +972,065	+2%	+$35.3M	0.48%	27
2019 Q2	$1.74B	Sell	42,336,892 -13,489,647	-24%	-$536M	0.56%	18
2019 Q1	$2.25B	Buy	55,826,539 +14,913,180	+36%	+$597M	0.76%	12
2018 Q4	$1.69B	Sell	40,913,359 -2,260,356	-5%	-$93.8M	0.62%	21
2018 Q3	$1.81B	Buy	43,173,715 +705,197	+2%	+$27.1M	0.54%	20
2018 Q2	$1.46B	Sell	42,468,518 -9,797,683	-19%	-$335M	0.45%	25
2018 Q1	$1.76B	Sell	52,266,201 -3,345,827	-6%	-$115M	0.52%	23
2017 Q4	$1.91B	Buy	55,612,028 +3,410,492	+7%	+$116M	0.57%	21
2017 Q3	$1.77B	Buy	52,201,536 +1,908,767	+4%	+$61.3M	0.57%	21
2017 Q2	$1.6B	Buy	50,292,769 +6,797,459	+16%	+$214M	0.54%	27
2017 Q1	$1.41B	Buy	43,495,310 +3,633,978	+9%	+$115M	0.49%	29
2016 Q4	$1.23B	Buy	39,861,332 +4,916,600	+14%	+$150M	0.46%	29
2016 Q3	$1.12B	Sell	34,944,732 -5,464,693	-14%	-$183M	0.45%	33
2016 Q2	$1.35B	Sell	40,409,425 -71,081,204	-64%	-$2.27B	0.57%	17
2016 Q1	$3.14B	Buy	111,490,629 +56,682,584	+103%	+$1.62B	1.29%	5
2015 Q4	$1.68B	Buy	54,808,045 +13,413,715	+32%	+$422M	0.69%	14
2015 Q3	$1.23B	Buy	41,394,330 +240,540	+0.6%	+$7.71M	0.56%	22
2015 Q2	$1.31B	Sell	41,153,790 -27,458,026	-40%	-$895M	0.53%	23
2015 Q1	$2.26B	Buy	68,611,816 +21,616,767	+46%	+$687M	0.94%	7
2014 Q4	$1.39B	Buy	46,995,049 +5,218,087	+12%	+$150M	0.6%	18
2014 Q3	$1.17B	Buy	41,776,962 +3,780,805	+10%	+$106M	0.51%	24
2014 Q2	$1.07B	Buy	37,996,157 +2,090,964	+6%	+$59.6M	0.44%	37
2014 Q1	$1.09B	Sell	35,905,193 -2,169,053	-6%	-$64.7M	0.48%	35
2013 Q4	$1.11B	Buy	38,074,246 +578,824	+2%	+$16.8M	0.5%	34
2013 Q3	$1.02B	Sell	37,495,422 -3,165,517	-8%	-$86.1M	0.54%	28
2013 Q2	$1.08B	Buy	+40,660,939	New	+$1.12B	0.6%	26